Role of the ETV5/p38 signaling axis in aggressive thyroid cancer cells
Jerry H. Houl, Rozita Bagheri‐Yarmand, Muthusamy Kunnimalaiyaan…·Marie-Claude C. Hofmann
This study identifies a link between the ETV5/p38 signaling axis and aggressive thyroid cancers, showing that combining p38 inhibitors with BRAF inhibitors improves treatment outcomes.